Age Features of Testosterone Deficiency in Men with Metabolic Syndrome and Diabetes Mellitus Type 2 (Literature Review with Own Data)
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Братусь В.В., Шуманов В.А., Талаева Т.В. Метаболический синдром: природа и механизмы развития // Журнал АМН України. – 2004. – Т. 10, № 4. – С. 646–670.
Доробнева Е.Ф., Пугачева Т.А., Медведева И.В. Метаболический синдром // Терапевтический архив. – 2002. – № 10. – С. 7–12.
Bloomgarden Z.T. Definitions of the insulin resistanse syndrome // Diabetes Care. – 2004. – 27. – P. 824–830. https://doi.org/10.2337/diacare.27.3.824
Cartier A., Lemieux I., Almeras N. Visceral obesity and plasma glucose-insulin homeostasis: contributions of IL-6 and TNF-α // Diabetologia. – 2007. – Vol. 50 (Suppl 1). – P. 270.
Зимин Ю.В. Происхождение, диагностическая концепция и клиническое значение синдрома инсулинорезистентности или метаболического синдрома Х // Кардиология. – 1998. – № 6. – С. 71–81.
Moller D.E., Kaufman K.D. Metabolic Syndrome: A Clinical and Molecular Perspective // Ann. Rev. Med. – 2005. – Vol. 56. – P. 45–62. https://doi.org/10.1146/annurev.med.56.082103.104751
Bjorntorp P, Rosmond R. Neuroendocrine abnormalities in visceral obesity // Int J Obes Renal Metab Disord. – 2000. Jun. – Vol. 24. Suppl 2. – P. 80–85. http://dx.doi.org/10.1038/sj.ijo.0801285
Kupelian V., Page S.T., Araujo A.B. et al. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men // J. Clin. Endocrinol. Metab. – 2006. – Vol. 91, № 3. – P. 843–850. https://doi.org/10.1210/jc.2005-1326
Kapoor D., Goodwin E, Channer K.S. et al. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolemia in hypogonadal men with type 2 diabetes // Eur J Endocrinol. – 2006. – Vol. 154. – P. 899–906. https://doi.org/10.1530/eje.1.02166
Chang T.C., Tung C.C., Hsiao Y.L. Hormonal changes in elderly men with non-insulin-dependent diabetes mellitus and the hormonal relationships to abdominal adiposity // Grontology. – 1994. – Vol. 40, N 5. – P. 260–267. https://doi.org/10.1159/000213594
Feldman H.A., Longcope C., Derby C.A. et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study // J. Clin. Endocrinol. Metab. – 2002. – Vol. 87. – P. 589–598. https://doi.org/10.1210/jcem.87.2.8201
Corrales J.J., Burgo R.M., Garca-Berrocal B. et al. Partial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic control // Metabolism. – 2004. – Vol. 53, № 5. – P. 666–672. http://dx.doi.org/10.1016/j.metabol.2003.12.016
Svartberg J., Jenssen T., Sundsfjord J. et al. The associations of endogenous testosterone and sex hormonebinding globulin with glycosylated hemoglobin levels, in communiti dwelling men. The Tromso Study // Diabetes Metab. – 2004. – Vol. 30, № 1. – P. 29–34. https://doi.org/10.1016/S1262-3636(07)70086-1
Watts L., Appleby N., Albanes D. et al. Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men. // PLOS ONE. – 2017 – № 12. – Vol. 12. – e0187741. https://doi.org/10.1371/journal.pone.0187741
Лучицький Є.В. Еректильна дисфункція та рівень статевих гормонів у крові чоловіків, хворих на цукровий діабет, у віковому аспекті. // Здоровье мужчины. – 2006. – № 2. – С. 217–219.
Тронько М.Д., Лучицький Є.В., Паньків В.І. Ендокринні аспекти метаболічного синдрому // Київ–Чернівці. – 2005. – 184 с.
Aksid S., Aydin M., Aksungar F.B. et al. Effect of androgen replacement therapy on cardiac risk markers // J.Sex. Med. – 2006. – Vol. 3 (Suppl. 3). – P. 232. https://doi.org/10.1111/j.1743-6109.2006.00188_4.x
Dhindsa S, Prabhacar S, Sethi M et al. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. // J Clin Endocrinol Metab. – 2004. – Vol. 89. – P. 5462–5468. https://doi.org/10.1210/jc.2004-0804
Corona G., Mannucci T., Petrone L., et al. Association of hypogonadism and type 2 diabetes in men attending an outpatient erectile dysfunction clinic // Int. J. Impot. Res. – 2006. – Vol. 18, № 2. – P. 190–197. https://doi.org/10.1038/sj.ijir.3901391
Shabsigh R . Obesity, metaboliс syndrome and sexual dysfunction // J. Sex. Med. – 2006. – Vol. 3 (suppl 5). – P. 345. https://doi.org/10.1111/j.1743-6109.2006.00313_2.x
Aversa A, Isidori A.M., Spega G. et al. Androgens improve cavernous vasodilatation and response to sildenafil in patients with erectile dysfunction. // Clin Endocrinol (Oxf). – 2003. – Vol. 58. – P. 632–638. http://dx.doi.org/10.1046/j.1365-2265.2003.01764.x
Лучицький Є.В., Кобяков С.К., Славнов В.М. Спосіб виявлення порушень гемодинаміки яєчок у чоловіків, хворих на цукровий діабет // Деклараційний патент на винахід. – К., 2003. – Бюллетень №1.
Лучицький Є.В., Кобяков С.К., Славнов В.М.,Ковпан Н.О. Радіонуклідна ангіографія та сцинтиграфія яєчок у хворих на цукровий діабет // Укр. радіол. журн. – 2002. – № 1. – С. 6–9. PDF
Makhsida N, Shah J, Yan G. et al. Hypogonadism and the metabolic syndrome, implications for testosterone therapy. // J. Urol. – 2005. – Vol. 174. – P. 827–834. https://doi.org/10.1097/01.ju.0000169490.78443.59
Aversa A, Grego E.A., Canale D. et al. A double-bling, randomized, placebo-controlled cross-over study on the effect of testosterone (Testogel) plus sildenafil on bone and metabolic parameters in men with mild hypogonadism and erectile dysfunction. // J Sex Med. – 2006. –Vol. 3. – P. 224–286. https://doi.org/10.1111/j.1743-6109.2006.00188_4.x
